PVA, TePla

PVA TePla: Why a 164% Jump in Orders Hasn’t Stopped the Share Slide

Published on 07/20/2026 at 17:23 | Redaktion boerse-global.de

PVA TePla posts record €121.6M Q1 orders (+164% YoY) but EBIT loss of €1.3M; stock down 20% from July peak. New Fraunhofer lab, insider buying, and 2026 guidance provide long-term outlook.

PVA TePla Orders Surge 164% But EBIT Loss Hits Stock – Fraunhofer Partnership
PVA TePla: Why a 164% Jump in Orders Hasn’t Stopped the Share Slide Illustration mit AI erstellt übermittelt durch boerse-global.de

PVA TePla’s order intake hit a record €121.6 million in the first quarter, surging 164% year-on-year and pushing the book-to-bill ratio to 1.9. Yet the semiconductor equipment maker’s stock has fallen more than 20% from its July peak of €46.70, as investors weigh an earnings slump that accompanied the demand boom. The tension between operational momentum and a bottom-line dip has become the dominant theme for the company, which just struck a research partnership with the Fraunhofer Institute for Integrated Systems and Device Technology (IISB).

The agreement, announced earlier this month, establishes a joint lab to develop aluminium nitride substrates for high-performance power electronics and radio-frequency applications. PVA TePla did not disclose financial terms. The collaboration adds a long-term technology pillar to a business that is already riding a wave of short-term demand from the semiconductor and aerospace sectors.

The Q1 figures explain both the optimism and the caution. Revenue came in at €54.9 million, while EBITDA reached €1.4 million. EBIT, however, swung to a loss of €1.3 million from a profit of €5.9 million a year earlier. Management attributed the red ink to planned upfront spending on personnel, infrastructure and sales capacity — investments intended to lock in future growth.

Should investors sell immediately? Or is it worth buying Pva Tepla?

At the annual general meeting in Giessen in June, CEO Jalin Ketter described an "operational turnaround" driven by the order surge. Shareholders backed the strategy, with 44.8% of capital represented, and the company reaffirmed its full-year 2026 guidance: revenue between €255 million and €275 million, and EBITDA between €26 million and €31 million. For context, fiscal 2025 produced revenue of €244.3 million and EBITDA of €25 million, meaning the current forecast implies moderate growth even as the order book suggests a stronger pipeline.

Despite that guidance and the record intake, the share price has been sinking. The stock recently changed hands at around €36.50, down roughly 4% on one previous session and 15% over the past 30 days. Year-to-date it still shows a gain of more than 60%, but the gap between the 52-week high and the current level underscores a market that is demanding proof that the investment phase will translate into profit.

Company insiders, however, have been buying. Ketter acquired shares worth €21,095 in November 2025, and board member Dr. Myriam Jahn purchased €21,800 worth at an average price of €21.80 per share in December. Both positions are comfortably in the money. The stock remains more than 90% above its 52-week low of €19.32 from February, suggesting the recent pullback is a consolidation within a longer uptrend rather than a reversal.

The next major test comes on 6 August, when PVA TePla releases its half-year report and holds an earnings call for the second quarter. Analysts will be looking for signs that the record order entry is feeding through to revenue and earnings. A few weeks later, on 25 August, the company will present at the Jefferies Semiconductor, IT Hardware & Communications Technology Conference, an event that could draw fresh institutional attention. Whether the operational story can regain the upper hand over the stock’s technical weakness will likely become clearer then.

Ad

Pva Tepla Stock: New Analysis - 20 July

Fresh Pva Tepla information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Pva Tepla analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0007461006 | PVA | boerse | 69814470 |